Acute Kidney Injury in The Critically ill Patient
A Review of Epidemiological Studies in Low-middle Income Countries
DOI:
https://doi.org/10.4314/Keywords:
acute kidney injury, low-middle income countries, critically ill patient, intensive care unit, epidemiology, developing countriesAbstract
Introduction
Acute kidney injury (AKI) refers to the sudden reduction in the kidney's ability to carry out its functions. AKI poses a major health burden in both low and middle income countries (LMIC) resulting in increased morbidity and mortality. It is a common complication in critically ill patients and has the potential of progressing to CKD.The objective of this article is to review the existing epidemiological studies on AKI in ICUs in LMIC.
Methods
Pubmed, Google Scholar, Web of Science and the Scientific Electronic Library online (SciELO) were searched for published reports, including article reviews on AKI in critically ill patients in LMIC. Search items included key words such as “acute kidney injury”, 'critically ill patient”, 'intensive care unit', 'epidemiology' low and middle income countries, 'developing countries'. The Search occurred between September to November 2022.Articles published from 2010 to 2022 were included in the search. The results reported according to PRISMA 2020 guidelines.
Results
Sixteen studies done in 13 LMIC were identified, with these studies analyzing data from 14835 patients from 51 ICUs within these countries from 2010 to 2022. Out of the studies reviewed, Six were from African countries and ten from non-African countries with male sex preponderance. The mean age of patients in the various studies ranged from 36 to 78 years with similar comorbidities reported such as hypertension, diabetes mellitus, stroke and heart failure. The overall incidence of AKI in ICU ranged from 29% to 58.5%. RIFLE criteria was used to define AKI in 4 of the reported studies with same number using AKIN criteria and lastly, KDIGO used in 8 studies. While most of the studies used just serum creatinine to define AKI, the study done by Passoni et al included urine output as well. Mortality rate was between 25.7%to 68%. Risk factors for AKI in critically ill patients reported from most of the studies reviewed include increasing age, male sex, sepsis, increasing length of ICU stay, hypovolemia and vasopressor use. Also, comorbidities such as hypertension (14%-46%) and diabetes mellitus (13%- 45.9%) was common among patients. The length of ICU stay varied from 2 to 45 days with longer duration of stay noticed for patients with AKI for those reported.
Conclusion
It is reasonable to conclude that the high incidence of AKI and its contributory factors are persistent in LMICs with the associated poor outcomes.
References
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care [Internet]. 2004 [cited 2021 Nov 15];8(4). Available from: https://pubmed.ncbi.nlm.nih.gov/15312219/
Ronco C, Bellomo R, Kellum JA. Acute kidney injury. Lancet (London, England) [Internet]. 2019 Nov 23 [cited 2021 Nov 23];394(10212):1949–64. Available from: https://pubmed.ncbi.nlm.nih.gov/31777389/
Thomas ME, Blaine C, Dawnay A, Devonald MAJ, Ftouh S, Laing C, et al. The definition of acute kidney injury and its use in practice. Kidney Int. 2015 Jan 1;87(1):62–73.
Nazrul M, Mondal I, Shitan M. Impact of Socio-Health Factors on Life Expectancy in the Low and Lower Middle Income Countries. Iran J Publ Heal [Internet]. 2013 [cited 2024 Feb 18];42(12):1354–62. Available from: http://ijph.tums.ac.ir
Middle Income Countries Overview: Development news, research, data | World Bank [Internet]. [cited 2024 Feb 18]. Available from: https://www.worldbank.org/en/country/mic/overview
Murray CJL, Lopez AD, Harvard School of Public Health., World Health Organization., World Bank. The global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 ; summary. Published by the Harvard School of Public Health on behalf of the World Health Organization and the World Bank; 1996. 43 p.
Odutayo A, Adhikari BNKJ, Barton MJ, Burns KEA, Friedrich JO, Klein D, et al. Epidemiology of acute kidney injury in Canadian critical care units : a prospective cohort study ´ pide ´ miologie des le ´ sions re ´ nales aigue ´ s de soins ¨ s dans les unite ´ tude prospective de cohorte intensifs au Canada : e. 2012;934–42.
Park WY, Hwang EA, Jang MH, Park SB, Kim HC. The Risk Factors and Outcome of Acute Kidney Injury in the Intensive Care Units. 2010;181–7.
Kahindo CK, Mukuku O, Wembonyama SO, Tsongo ZK. Prevalence and Factors Associated with Acute Kidney Injury in Sub-Saharan African Adults: A Review of the Current Literature. Int J Nephrol [Internet]. 2022 [cited 2022 Oct 2];2022. Available from: https://pubmed.ncbi.nlm.nih.gov/35342649/
Halle MPE, Chipekam NM, Beyiha G, Fouda H, Coulibaly A, Hentchoya R, et al. Incidence, characteristics and prognosis of acute kidney injury in Cameroon: a prospective study at the Douala General Hospital. Ren Fail [Internet]. 2018 Nov 1 [cited 2022 Oct 4];40(1):30–7. Available from: https://europepmc.org/articles/PMC6014289
Banda J, Chenga N, Nambaya S, Bulaya T, Siziya S. Predictors of Acute Kidney Injury and Mortality in Intensive Care Unit at a Teaching Tertiary Hospital_ID. Indian J Crit Care Med [Internet]. 2020 [cited 2022 Oct 2];24(2):116. Available from: /pmc/articles/PMC7075058/
Passoni R, Rodrigues A, Alberto L, Peres B. Incidence and risk factors of acute kidney injury in critically ill patients from a single centre in Brazil : a retrospective cohort analysis. Sci Rep [Internet]. 2019;1–8. Available from: http://dx.doi.org/10.1038/s41598-019-54674-1
Adelaja MA, Okunola OO, Arogundade FA, Oyebisi O, Erohubie CE, Faponle AF, et al. Pattern and prognostic factors of acute kidney injury in an intensive care unit in Nigeria. Afr J Med Med Sci [Internet]. 2019 [cited 2022 Sep 25];48(3):379–87. Available from: http://ojshostng.com/index.php/ajmms/article/view/292
Mumin A, Ahmed S, Hassan N, Eltahir M. Incidence and Risk Factors of Acute Kidney Injury in ICU Patients of Omdurman Teaching Hospital. 2021;43–57.
Jiang L, Zhu Y, Luo X, Wen Y, Du B, Wang M, et al. Epidemiology of acute kidney injury in intensive care units in Beijing: The multi-center BAKIT study. BMC Nephrol. 2019 Dec 16;20(1).
Masewu A, Makulo JR, Lepira F, Amisi EB, Kiswaya Sumaili E, Bukabau J, et al. Acute kidney injury is a powerful independent predictor of mortality in critically ill patients: a multicenter prospective cohort study from Kinshasa, the Democratic Republic of Congo. undefined. 2016;17(1).
Minja NW, Akrabi H, Yeates K, Kilonzo KG. Acute Kidney Injury and Associated Factors in Intensive Care Units at a Tertiary Hospital in Northern Tanzania. undefined [Internet]. 2021 [cited 2022 Oct 2];8. Available from: https://doi.org/10.1177/20543581211027971
Aylward RE, Van Der Merwe E, Pazi S, Van Niekerk M, Ensor J, Baker D, et al. Risk factors and outcomes of acute kidney injury in South African critically ill adults: a prospective cohort study. BMC Nephrol [Internet]. 2019 Dec 10 [cited 2022 Oct 2];20(1):460–460. Available from: https://europepmc.org/articles/PMC6902455
Oweis AO, Alshelleh SA, Momany SM, Samrah SM, Khassawneh BY, Al Ali MAK. Incidence, Risk Factors, and Outcome of Acute Kidney Injury in the Intensive Care Unit: A Single-Center Study from Jordan. Crit Care Res Pract. 2020;2020.
Kim MH, Koh SO, Kim EJ, Cho JS, Na SW. Incidence and outcome of contrast-associated acute kidney injury assessed with Risk, Injury, Failure, Loss, and End-stage kidney disease (RIFLE) criteria in critically ill patients of medical and surgical intensive care units: a retrospective study. undefined. 2015 Mar 3;15(1).
LG Y, BM S, E R, AL B, D P. Acute kidney injury in elderly intensive care patients from a developing country: clinical features and outcome. Int J Nephrol Renovasc Dis [Internet]. 2017 Feb 1 [cited 2022 Nov 16];Volume 10:27–33. Available from: https://doaj.org/article/ddc5d06f87fd44bbb27075047271f192
Dos Santos LL, Da Silva Magro MC. Mechanical ventilation and acute kidney injury in patients in the intensive care unit. ACTA Paul Enferm. 2015 Mar 1;28(2):146–51.
Herrera-Méndez J, Sánchez-Velázquez LD, González-Chávez A, Rodríguez-Terán G. Incidence of the acute renal failure in the intensive care unit at the General Hospital of Mexico: Risk factors and associated morbidity and mortality. Rev Médica Del Hosp Gen México [Internet]. 2015 Apr [cited 2022 Nov 16];78(2):62–6. Available from: https://www.researchgate.net/publication/282633330_Incidence_of_the_acute_renal_failure_in_the_intensive_care_unit_at_the_General_Hospital_of_Mexico_Risk_factors_and_associated_morbidity_and_mortality
Boltansky Brenner A, Bassa C, Melani S, Sepúlveda A, Maldonado I, Postigo J, et al. [Incidence and consequences of acute kidney injury among patients admitted to critical care units]. Rev Med Chil [Internet]. 2015 Sep 1 [cited 2022 Nov 16];143(9):1114–20. Available from: https://pubmed.ncbi.nlm.nih.gov/26530193/
Pickkers P, Darmon M, Hoste E, Joannidis M, Legrand M, Ostermann M, et al. Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med. 2021 Aug 1;47(8):835–50.
Okunola OO, Arogundade FA, Sanusi AA, Akinsola A. Acute renal failure in the intensive care unit: aetiological and predisposing factors and outcome. West Afr J Med [Internet]. 2009 Jul 1 [cited 2022 Jan 7];28(4):240–4. Available from: https://europepmc.org/article/med/20425739
Okoye O, Unuigbe E, Ojogwu L. Acute Kidney Injury in Adult Nigerians: A Single Centre Experience. undefined. 2017;
Kahindo CK, Mukuku O, Wembonyama SO, Tsongo ZK. Prevalence and Factors Associated with Acute Kidney Injury in Sub-Saharan African Adults: A Review of the Current Literature. Int J Nephrol [Internet]. 2022 [cited 2022 Oct 2];2022. Available from: /pmc/articles/PMC8941586/
Downloads
Published
Issue
Section
License
Copyright (c) 2025 African Journal of Tropical Medicine and Biomedical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
COPYRIGHT LICENSE
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0
International Public License
Section 1 -- Definitions.
a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
b. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.
c. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
d. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
e. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
f. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
g. Licensor means the individual(s) or entity(ies) granting rights under this Public License.
h. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.
i. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
j. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
k. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.
Section 2 -- Scope.
a. License grant.
- Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:
a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and
b. produce and reproduce, but not Share, Adapted Material for NonCommercial purposes only.
-
Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
-
Term. The term of this Public License is specified in Section 6(a).
-
Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a)(4) never produces Adapted Material.
-
Downstream recipients.
a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
- No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).
b. Other rights.
-
Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
-
Patent and trademark rights are not licensed under this Public License.
-
To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.
Section 3 -- License Conditions.
Your exercise of the Licensed Rights is expressly made subject to the following conditions.
a. Attribution.
- If You Share the Licensed Material, You must:
a. retain the following if it is supplied by the Licensor with the Licensed Material:
i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
ii. a copyright notice;
iii. a notice that refers to this Public License;
iv. a notice that refers to the disclaimer of warranties;
v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
For the avoidance of doubt, You do not have permission under this Public License to Share Adapted Material.
-
You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
-
If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.
Section 4 -- Sui Generis Database Rights.
Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:
a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only and provided You do not Share Adapted Material;
b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.
For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.
Section 5 -- Disclaimer of Warranties and Limitation of Liability.
a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.
b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.
c. The disclaimer of warranties and
limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.
Section 6 -- Term and Termination.
a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.
b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:
-
automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
-
upon express reinstatement by the Licensor.
For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.
c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.
Section 7 -- Other Terms and Conditions.
a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.
Section 8 -- Interpretation.
a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.
How to Cite
